List of works - Antonio Pisani

6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial.

scientific article published on 9 October 2015

A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report

scientific article

A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency

scientific article published on 01 July 2012

A strange epigastric pain.

scientific article published on 21 August 2014

Acute kidney injury by radiographic contrast media: pathogenesis and prevention.

scientific article

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

scientific article published on 01 May 1999

Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?

scientific article published on 10 July 2014

Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy

scientific article published on 05 December 2007

Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study.

scientific article published on 12 April 2017

Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study

scientific article published on 20 August 2014

Arterial aneurysms: autosomal dominant polycystic kidney disease, Marfan syndrome or both?

scientific article published on 10 October 2013

Atorvastatin improves the course of ischemic acute renal failure in aging rats.

scientific article published in April 2004

Atrial septum aneurysm: an unusual manifestation in ADPKD?

scientific article published on 17 April 2015

Author response: Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study.

scientific article published in October 2017

Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review

scientific article

Cardiac performance during exercise in patients with Fabry's disease

scientific article published on 01 December 2008

Catheter-based renal denervation in ADPKD: just for pain control?

scientific article published on 19 November 2014

Clinical treatment of polycystic kidney disease (APKD): do we need further suggestions from rodents?

scientific article published on 23 March 2011

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

scientific article

Complications of native arteriovenous fistula: the role of color Doppler ultrasonography.

scientific article

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

scientific article

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.

scientific article published on 28 September 2017

Differential activation of signaling pathways by low-osmolar and iso-osmolar radiocontrast agents in human renal tubular cells

scientific article published on 01 February 2014

EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects.

scientific article published on 28 July 2009

Early markers of Fabry disease revealed by proteomics.

scientific article published on June 2015

Effect of a Short-Course Treatment with Synbiotics on Plasma p-Cresol Concentration in Kidney Transplant Recipients.

scientific article published on 12 September 2017

Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury.

scientific article published on 27 June 2013

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

scientific article

Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial

scientific article published on 13 November 2014

Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial.

scientific article

Effects of combined administration of rapamycin, tolvaptan, and AEZ-131 on the progression of polycystic disease in PCK rats.

scientific article published on 19 March 2014

Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study.

scientific article published on 15 April 2009

Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study

scientific article published on 9 January 2014

Endocrine dysfunction in patients with Fabry disease.

scientific article published on 22 August 2006

Endothelial-mediated coronary flow reserve in patients with Anderson-Fabry disease

scientific article published on 05 November 2014

Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement

scientific article published in July 2005

Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature ⬇️

scientific article published on August 11, 2012

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease

scientific article published on 01 August 2004

Erratum to: Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study

scientific article published on 01 February 2016

Fanconi syndrome with lysinuric protein intolerance.

scientific article

First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease

scientific article published on 26 March 2015

Genetic variants associated with Fabry disease progression despite enzyme replacement therapy

scientific article published on 18 November 2017

Genetic variants associated with gastrointestinal symptoms in Fabry disease.

scientific article published on 5 November 2016

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group

scientific article

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study

scientific article published on 22 June 2015

Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease

scientific article published on 24 November 2015

Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease

scientific article published on February 2016

MRI characterization of myocardial tissue in patients with Fabry's disease

scientific article published on 01 March 2007

Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.

scientific article published on 19 May 2015

Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study ⬇️

scientific article published on February 28, 2012

Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial.

scientific article published on 2 November 2007

Molecular and clinical studies in five index cases with novel mutations in the GLA gene

scientific article published on 12 December 2015

Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media

scientific article published on 18 March 2014

Motor involvement in Fabry disease.

scientific article published on 21 December 2017

Mycophenolic acid inhibits the phosphorylation of NF-kappaB and JNKs and causes a decrease in IL-8 release in H2O2-treated human renal proximal tubular cells.

scientific article published on 17 March 2010

Nephrotic syndrome and autosomal dominant polycystic kidney disease

scientific article

Nutritional treatment in chronic kidney disease: the concept of nephroprotection.

scientific article

Pituitary function and morphology in Fabry disease.

scientific article published on 21 April 2015

Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.

scientific article published on 20 November 2017

Pleural effusion in peritoneal dialysis: overload or leakage? ⬇️

scientific article published on March 16, 2013

Polycystic horseshoe kidney

scientific article published on 20 February 2013

Prevalence of hepatitis C virus infection in different population groups in southern Italy.

scientific article published in February 2005

Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors

scientific article published on 30 November 2014

Quercetin protects against radiocontrast medium toxicity in human renal proximal tubular cells

scientific article published on 16 October 2017

Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study

scientific article published on 10 July 2012

Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.

scientific article

Redefining the Pulvinar Sign in Fabry Disease.

scientific article published on 19 October 2017

Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease

scientific article published on 7 December 2015

Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease

scientific article published on 12 March 2014

Reversal of radiocontrast medium toxicity in human renal proximal tubular cells by white grape juice extract

scientific article

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome

scientific article published on 30 January 2014

Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.

scientific article

Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy.

scientific article published on 29 December 2013

Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact

scientific article published on 16 June 2009

Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin

scientific article published on 01 November 2011

Sleep quality in patients with chronic renal failure: a 3-year longitudinal study

scientific article published on 20 July 2007

Sleep quality in renal transplant patients: a never investigated problem

scientific article

Switch to agalsidase alfa after shortage of agalsidase beta in Fabry disease: a systematic review and meta-analysis of the literature.

scientific article published on 8 September 2016

Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease.

scientific article published on 22 August 2013

Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease

scientific article published on 21 December 2011

The impact of haemoglobin on the quality of sleep in haemodialysis patients: which is the truth?

scientific article published in September 2003

The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice

scientific article published on 21 December 2016

The kidney in Fabry's disease

scientific article published on 30 May 2014

The potential use of biomarkers in predicting contrast-induced acute kidney injury

scientific article

What indication, morbidity and mortality for central pancreatectomy in oncological surgery? A systematic review.

scientific article published on 18 December 2015

Zaleplon improves sleep quality in maintenance hemodialysis patients

scientific article published on 01 January 2003

List of works by Antonio Pisani

6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial.

A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report

A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency

A strange epigastric pain.

Acute kidney injury by radiographic contrast media: pathogenesis and prevention.

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?

Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy

Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study.

Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study

Arterial aneurysms: autosomal dominant polycystic kidney disease, Marfan syndrome or both?

Atorvastatin improves the course of ischemic acute renal failure in aging rats.

Atrial septum aneurysm: an unusual manifestation in ADPKD?

Author response: Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study.

Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review

Cardiac performance during exercise in patients with Fabry's disease

Catheter-based renal denervation in ADPKD: just for pain control?

Clinical treatment of polycystic kidney disease (APKD): do we need further suggestions from rodents?

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

Complications of native arteriovenous fistula: the role of color Doppler ultrasonography.

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.

Differential activation of signaling pathways by low-osmolar and iso-osmolar radiocontrast agents in human renal tubular cells

EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects.

Early markers of Fabry disease revealed by proteomics.

Effect of a Short-Course Treatment with Synbiotics on Plasma p-Cresol Concentration in Kidney Transplant Recipients.

Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury.

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial

Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial.

Effects of combined administration of rapamycin, tolvaptan, and AEZ-131 on the progression of polycystic disease in PCK rats.

Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study.

Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study

Endocrine dysfunction in patients with Fabry disease.

Endothelial-mediated coronary flow reserve in patients with Anderson-Fabry disease

Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement

Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature ⬇️

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease

Erratum to: Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study

Fanconi syndrome with lysinuric protein intolerance.

First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease

Genetic variants associated with Fabry disease progression despite enzyme replacement therapy

Genetic variants associated with gastrointestinal symptoms in Fabry disease.

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study

Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease

Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease

MRI characterization of myocardial tissue in patients with Fabry's disease

Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.

Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study ⬇️

Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial.

Molecular and clinical studies in five index cases with novel mutations in the GLA gene

Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media

Motor involvement in Fabry disease.

Mycophenolic acid inhibits the phosphorylation of NF-kappaB and JNKs and causes a decrease in IL-8 release in H2O2-treated human renal proximal tubular cells.

Nephrotic syndrome and autosomal dominant polycystic kidney disease

Nutritional treatment in chronic kidney disease: the concept of nephroprotection.

Pituitary function and morphology in Fabry disease.

Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.

Pleural effusion in peritoneal dialysis: overload or leakage? ⬇️

Polycystic horseshoe kidney

Prevalence of hepatitis C virus infection in different population groups in southern Italy.

Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors

Quercetin protects against radiocontrast medium toxicity in human renal proximal tubular cells

Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study

Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.

Redefining the Pulvinar Sign in Fabry Disease.

Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease

Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease

Reversal of radiocontrast medium toxicity in human renal proximal tubular cells by white grape juice extract

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome

Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.

Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy.

Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact

Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin

Sleep quality in patients with chronic renal failure: a 3-year longitudinal study

Sleep quality in renal transplant patients: a never investigated problem

Switch to agalsidase alfa after shortage of agalsidase beta in Fabry disease: a systematic review and meta-analysis of the literature.

Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease.